{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:14:40Z","timestamp":1794118480138,"version":"4.8.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejmech.2025.117384","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T07:59:32Z","timestamp":1739433572000},"page":"117384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Discovery of \u03b2-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1\u2212nuclear factor erythroid 2-related factor 2 (Keap1\u2212Nrf2) protein\u2212protein interaction inhibitors for ulcerative colitis management"],"prefix":"10.1016","volume":"288","author":[{"given":"Ziquan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shicheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qidong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117384_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117384_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.05.086","article-title":"Oxidative stress in autoimmune rheumatic diseases","volume":"125","author":"Smallwood","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.117384_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1089\/ars.2017.7382","article-title":"Oxidative modifications in tissue pathology and autoimmune disease","volume":"29","author":"Yang","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2025.117384_bib4","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117384_bib5","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.117384_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/17460441.2020.1791077","article-title":"Drug discovery strategies for modulating oxidative stress in gastrointestinal disorders","volume":"15","author":"Mousavi","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117384_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.molmed.2020.06.006","article-title":"Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease","volume":"26","author":"Bourgonje","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117384_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5853238","article-title":"Oxidative stress and inflammation in cardiovascular disease","volume":"2017","author":"Garcia","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2025.117384_bib9","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/eurheartj\/ehv679","article-title":"Ageing, inflammation, and oxidative stress: final common pathways of cardiovascular disease","volume":"36","author":"Luscher","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejmech.2025.117384_bib10","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2025.117384_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.117.014753","article-title":"Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach","volume":"70","author":"Cuadrado","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2025.117384_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117384_bib13","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2025.117384_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2025.117384_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.117384_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117384_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2025.117384_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2020.06.028","article-title":"Transcription factor NRF2 as a promising therapeutic target for Alzheimer\u2019s disease","volume":"159","author":"Qu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.117384_bib19","doi-asserted-by":"crossref","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","article-title":"Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib20","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1021\/acs.jmedchem.9b01865","article-title":"Emerging substrate proteins of Kelch-like ECH associated protein 1 (Keap1) and potential challenges for the development of small-molecule inhibitors of the Keap1-nuclear factor erythroid 2-related factor 2 (Nrf2) protein-protein interaction","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1101\/gad.13.1.76","article-title":"Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain","volume":"13","author":"Itoh","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.117384_bib22","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.apsb.2022.02.022","article-title":"Non-small molecule PROTACs (NSM-PROTACs): protein degradation kaleidoscope","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117384_bib23","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1128\/MCB.24.19.8477-8486.2004","article-title":"The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase","volume":"24","author":"Cullinan","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117384_bib25","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","article-title":"Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants","volume":"617","author":"Dinkova-Kostova","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.117384_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.biotechadv.2014.03.004","article-title":"Monitoring Keap1-Nrf2 interactions in single live cells","volume":"32","author":"Baird","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejmech.2025.117384_bib28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s42003-021-02100-6","article-title":"Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism","volume":"4","author":"Horie","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/MCB.26.1.221-229.2006","article-title":"Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1","volume":"26","author":"Kobayashi","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib30","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2025.117384_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13543776.2023.2178299","volume":"33","author":"Zhao","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2025.117384_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158466","article-title":"An overview of NRF2-activating compounds bearing alpha,beta-unsaturated moiety and their antioxidant effects","volume":"23","author":"Egbujor","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117384_bib33","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1021\/acs.jmedchem.6b00586","article-title":"Discovery and development of Kelch-like ECH-associated protein 1. Nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction inhibitors: achievements, challenges, and future directions","volume":"59","author":"Jiang","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib34","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.1021\/acs.jmedchem.3c00712","article-title":"Medicinal chemistry insights into the development of small-molecule Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) protein-protein interaction inhibitors","volume":"66","author":"Zhao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1039\/C6MD00500D","article-title":"Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function","volume":"8","author":"Zhuang","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2025.117384_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117384_bib37","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases","volume":"61","author":"Pallesen","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib38","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.chembiol.2023.12.005","article-title":"Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response","volume":"31","author":"Lu","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112532","article-title":"Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors","volume":"202","author":"Mou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib40","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.1021\/acs.jmedchem.9b00723","article-title":"A comparative assessment study of known small-molecule Keap1-Nrf2 protein-protein interaction inhibitors: chemical synthesis, binding properties, and cellular activity","volume":"62","author":"Tran","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib41","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib42","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1515\/BC.2006.164","article-title":"Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism","volume":"387","author":"Tong","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117384_bib44","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cbic.201800170","article-title":"Modified peptide inhibitors of the Keap1-Nrf2 protein-protein interaction incorporating unnatural amino acids","volume":"19","author":"Georgakopoulos","year":"2018","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.117384_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.freeradbiomed.2011.10.486","article-title":"Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction","volume":"52","author":"Hancock","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.117384_bib46","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1021\/acs.jmedchem.4c00065","article-title":"Cyclic peptide Keap1-Nrf2 protein-protein interaction inhibitors: design, synthesis, and in vivo treatment of acute lung injury","volume":"67","author":"Zou","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311467","article-title":"Inhibiting the Keap1\/Nrf2 protein-protein interaction with protein-like polymers","volume":"36","author":"Carrow","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejmech.2025.117384_bib48","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejmech.2017.10.052","article-title":"Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency","volume":"143","author":"Lu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib49","article-title":"Peptide-hypervalent iodine reagent chimeras: enabling peptide functionalization and macrocyclization","volume":"62","author":"Liu","year":"2023","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.117384_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1-NRF2 protein-protein interaction inhibitors: design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117384_bib51","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01687","article-title":"Discovery of propionic acid derivatives with a 5-THIQ core as potent and orally bioavailable Keap1-Nrf2 protein-protein interaction inhibitors for acute kidney injury","author":"Shi","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib52","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.bmcl.2013.03.013","article-title":"Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction","volume":"23","author":"Hu","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117384_bib53","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01221","article-title":"Structure-guided conformational restriction leading to high-affinity, selective, and cell-active tetrahydroisoquinoline-based noncovalent Keap1-Nrf2 inhibitors","author":"Qin","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib54","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.bmc.2013.04.019","article-title":"Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism","volume":"21","author":"Marcotte","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib55","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib56","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1021\/acs.jmedchem.2c00170","article-title":"Crystallography-guided optimizations of the Keap1-Nrf2 inhibitors on the solvent exposed region: from symmetric to asymmetric naphthalenesulfonamides","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104172","article-title":"Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer\u2019s disease","volume":"103","author":"Sun","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114380","article-title":"Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N'-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"237","author":"Lee","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib59","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein-protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib60","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1021\/acs.jmedchem.3c02171","article-title":"Optimization efforts for Identification of novel highly potent Keap1-Nrf2 protein-protein interaction inhibitors","volume":"67","author":"Otake","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib61","doi-asserted-by":"crossref","first-page":"11149","DOI":"10.1021\/acs.jmedchem.0c01116","article-title":"Design, synthesis, and structure-activity relationships of indoline-based Kelch-like ECH-associated protein 1-nuclear factor (Erythroid-Derived 2)-like 2 (Keap1-Nrf2) protein-protein interaction inhibitors","volume":"63","author":"Zhou","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib62","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1021\/acs.jmedchem.0c02094","article-title":"Deconstructing noncovalent Kelch-like ECH-associated protein 1 (Keap1) inhibitors into fragments to reconstruct new potent compounds","volume":"64","author":"Pallesen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib63","doi-asserted-by":"crossref","first-page":"15949","DOI":"10.1021\/acs.jmedchem.1c01351","article-title":"Fragment-guided discovery of Pyrazole carboxylic acid inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2 related factor 2 (KEAP1:NRF2) protein-protein interaction","volume":"64","author":"Norton","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","article-title":"An open-source drug discovery platform enables ultra-large virtual screens","volume":"580","author":"Gorgulla","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117384_bib65","article-title":"Novel hydrogen sulfide hybrid derivatives of Keap1-Nrf2 protein-protein interaction inhibitor alleviate inflammation and oxidative stress in acute experimental colitis","volume":"12","author":"Zhang","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.117384_bib66","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","article-title":"Reaching for high-hanging fruit in drug discovery at protein-protein interfaces","volume":"450","author":"Wells","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117384_bib67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2015.08.049","article-title":"Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators","volume":"103","author":"Jain","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib68","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.jmedchem.5b00185","article-title":"Structure-activity and structure-property relationship and exploratory in vivo evaluation of the nanomolar Keap1-Nrf2 protein-protein interaction inhibitor","volume":"58","author":"Jiang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib69","doi-asserted-by":"crossref","first-page":"6796","DOI":"10.1021\/acs.jmedchem.9b00818","article-title":"Discovery of a potent Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Keap1-Nrf2) protein-protein interaction inhibitor with natural proline structure as a cytoprotective agent against acetaminophen-induced hepatotoxicity","volume":"62","author":"Lu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib70","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.1021\/acs.jmedchem.3c00686","article-title":"Fragment-based discovery of azocyclic alkyl naphthalenesulfonamides as Keap1-Nrf2 inhibitors for acute lung injury treatment","volume":"66","author":"Yan","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117384_bib71","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/acsmedchemlett.3c00067","article-title":"Methyl and fluorine effects in novel orally bioavailable Keap1-Nrf2 PPI inhibitor","volume":"14","author":"Otake","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117384_bib72","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.117384_bib73","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117384_bib74","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1053\/j.gastro.2022.01.023","article-title":"What does disease progression look like in ulcerative colitis, and how might it Be prevented?","volume":"162","author":"Krugliak Cleveland","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117384_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1200111","article-title":"The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117384_bib76","article-title":"An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis","volume":"6","author":"Lu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117384_bib77","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41467-018-07859-7","article-title":"Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway","volume":"10","author":"Singh","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117384_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101562","article-title":"Cell membrane vesicles with enriched CXCR4 display enhances their targeted delivery as drug carriers to inflammatory sites","volume":"8","author":"Wang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2025.117384_bib79","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/d41586-018-07277-1","article-title":"Ulcerative colitis: towards remission","volume":"563","author":"Eisenstein","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117384_bib80","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117384_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2014.357","article-title":"Treatment of IBD: where we are and where we are going","volume":"110","author":"Bernstein","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2025.117384_bib82","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1038\/s41598-022-13655-7","article-title":"A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent","volume":"12","author":"Koyama","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117384_bib83","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2025.117384_bib84","doi-asserted-by":"crossref","first-page":"308re308","DOI":"10.1126\/scitranslmed.aad3740","article-title":"Antioxidants can increase melanoma metastasis in mice","volume":"7","author":"Le Gal","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2025.117384_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112734","article-title":"Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions","volume":"207","author":"Lu","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T23:45:57Z","timestamp":1740786357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425001497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":85,"alternative-id":["S0223523425001497"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117384","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of \u03b2-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1\u2212nuclear factor erythroid 2-related factor 2 (Keap1\u2212Nrf2) protein\u2212protein interaction inhibitors for ulcerative colitis management","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117384"}}